Mikael K Poulsen
Overview
Explore the profile of Mikael K Poulsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Falster C, Morkenborg M, Thrane M, Clausen J, Arvig M, Brockhattingen K, et al.
Lancet Reg Health Eur
. 2024 Jul;
42:100941.
PMID: 39070742
Background: Prevalence of pulmonary embolism (PE) in patients referred to diagnostic imaging is decreasing, indicating a need for improving patient selection. The aim of this study was to assess reduction...
2.
Christophorou E, Nilsson A, Petersen I, Lindvig S, Davidsen J, Abazi R, et al.
Front Immunol
. 2023 Dec;
14:1270814.
PMID: 38090591
Background: In solid organ transplant (SOT) recipients, the humoral response following COVID-19 vaccination is reduced, as a result of their immunosuppressed treatment. In this study, we investigated antibody concentrations after...
3.
Malmborg M, Assad Turky Al-Kahwa A, Kober L, Torp-Pedersen C, Butt J, Zahir D, et al.
PLoS One
. 2023 Jun;
18(6):e0286307.
PMID: 37289772
Background: Whether continued follow-up in specialized heart failure (HF) clinics after optimization of guideline-directed therapy improves long-term outcomes in patients with HF with reduced ejection fraction (HFrEF) is unknown. Methods...
4.
Balsby D, Nilsson A, Petersen I, Lindvig S, Davidsen J, Abazi R, et al.
Front Immunol
. 2022 Dec;
13:1039245.
PMID: 36569919
Background: Solid organ transplant (SOT) recipients have shown suboptimal antibody response following COVID-19 vaccination. Several risk factors for the diminished response have been identified including immunosuppression and older age, but...
5.
Andersen C, Omar M, Glenthoj A, El Fassi D, Moller H, Lindholm Kurtzhals J, et al.
Eur J Heart Fail
. 2022 Nov;
25(2):226-234.
PMID: 36377106
Aims: It remains unknown whether the consistently observed increase in haematocrit with sodium-glucose cotransporter 2 inhibitors is caused by diuresis-associated haemoconcentration or increased erythropoiesis. We aimed to investigate the early...
6.
Falster C, Egholm G, Jacobsen N, Poulsen M, Posth S, Moller J, et al.
J Ultrasound
. 2022 Sep;
26(3):663-672.
PMID: 36114986
Purpose: The purpose of this descriptive feasibility study was to assess the clinical impact and feasibility of conducting a multiorgan ultrasound examination of patients with pulmonary embolism at both time...
7.
Olsen L, Kjeldsen A, Poulsen M, Kjeldsen J, Fialla A
Orphanet J Rare Dis
. 2020 Nov;
15(1):334.
PMID: 33243256
Background: This report addresses how patients with hereditary hemorrhagic telangiectasia (HHT) and high output cardiac failure (HOCF) due to hepatic vascular malformations, should be evaluated and could be treated. HHT...
8.
Dahl J, Barros-Gomes S, Videbaek L, Poulsen M, Issa I, Carter-Storch R, et al.
JACC Cardiovasc Imaging
. 2016 Apr;
9(5):519-28.
PMID: 27085434
Objectives: This study examined the impact of early mitral inflow velocity-to-early diastolic strain rate (E/SRe) ratio on long-term outcome after aortic valve replacement (AVR) in aortic stenosis (AS). Background: In...
9.
Poulsen M, Dahl J, Kjeldsen B, Norregaard-Hansen K, Pedersen K, Mickley H, et al.
Scand Cardiovasc J
. 2015 Feb;
49(1):49-55.
PMID: 25658150
Background: As patients with severe aortic valve stenosis (AS) develop symptoms their survival decreases rapidly, if treated conservatively. Transcatheter aortic valve implantation (TAVI) has been introduced as a less invasive...
10.
Bar-Shalom D, Poulsen M, Rasmussen L, Diederichsen A, Sand N, Henriksen J, et al.
Diab Vasc Dis Res
. 2014 Aug;
11(6):448-50.
PMID: 25097143
Recently, copeptin was found associated with cardiovascular disease (CVD) and all-cause mortality in type 2 diabetes mellitus (T2DM) patients treated in primary care. This study aimed to evaluate whether plasma...